Logo image of HSPO

HORIZON SPACE ACQUISITION I (HSPO) Stock Fundamental Analysis

NASDAQ:HSPO - Nasdaq - KYG4619M1096 - Common Stock - Currency: USD

11.65  -0.13 (-1.1%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to HSPO. HSPO was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of HSPO have multiple concerns. HSPO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HSPO was profitable.
HSPO had a negative operating cash flow in the past year.
HSPO Yearly Net Income VS EBIT VS OCF VS FCFHSPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 1M 2M

1.2 Ratios

Industry RankSector Rank
ROA 3.73%
ROE 3.99%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HSPO Yearly ROA, ROE, ROICHSPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 1 2 3 4

1.3 Margins

HSPO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HSPO Yearly Profit, Operating, Gross MarginsHSPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, HSPO has less shares outstanding
Compared to 1 year ago, HSPO has a worse debt to assets ratio.
HSPO Yearly Shares OutstandingHSPO Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M 8M
HSPO Yearly Total Debt VS Total AssetsHSPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M

2.2 Solvency

HSPO has an Altman-Z score of 13.38. This indicates that HSPO is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.02 indicates that HSPO is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 13.38
ROIC/WACCN/A
WACCN/A
HSPO Yearly LT Debt VS Equity VS FCFHSPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.09 indicates that HSPO may have some problems paying its short term obligations.
HSPO has a Quick Ratio of 0.09. This is a bad value and indicates that HSPO is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
HSPO Yearly Current Assets VS Current LiabilitesHSPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 200K 400K 600K

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 3466.10% over the past year.
EPS 1Y (TTM)3466.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HSPO Yearly Revenue VS EstimatesHSPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023
HSPO Yearly EPS VS EstimatesHSPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.83, the valuation of HSPO can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.63, HSPO is valued a bit more expensive.
Industry RankSector Rank
PE 38.83
Fwd PE N/A
HSPO Price Earnings VS Forward Price EarningsHSPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HSPO Per share dataHSPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HSPO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HORIZON SPACE ACQUISITION I

NASDAQ:HSPO (2/21/2025, 8:26:07 PM)

11.65

-0.13 (-1.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners25.74%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner Change0%
Market Cap91.22M
AnalystsN/A
Price TargetN/A
Short Float %0.04%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 38.83
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.57
P/tB 1.57
EV/EBITDA N/A
EPS(TTM)0.3
EY2.58%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS0
BVpS7.43
TBVpS7.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.73%
ROE 3.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z 13.38
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3466.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-56.11%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-300.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-152.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-152.09%
OCF growth 3YN/A
OCF growth 5YN/A